| Perrotin, Franck |
| Terminated | 3 | 429 | Europe, RoW | Balloon catheter + oral misoprostol, Oral misoprostol alone | University Hospital, Toulouse | Maternal Obesity | 02/23 | 02/23 | | |
APPART, NCT05625724: Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology |
|
|
| Recruiting | 3 | 1164 | Europe | Aspirin, Placebo | University Hospital, Toulouse | ART, Pre-Eclampsia | 05/25 | 05/26 | | |
PREGRALL, NCT03183440: Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children |
|
|
| Recruiting | N/A | 376 | Europe | PREBIOTICS, PLACEBO | Nantes University Hospital | Dermatitis, Atopic | 08/23 | 08/23 | | |
FETH, NCT03648645: Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure |
|
|
| Active, not recruiting | N/A | 50 | Europe | Self measurement of blood pressure | Rennes University Hospital | Hypertension in Pregnancy | 11/23 | 11/23 | | |
Antenatal, NCT03116217: Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves |
|
|
| Recruiting | N/A | 400 | Europe | | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Posterior Urethral Valves | 12/23 | 12/23 | | |
| Recruiting | N/A | 322 | Europe | | University Hospital, Brest | Cholestasis of Pregnancy | 06/25 | 06/25 | | |
RANSPRE, NCT05521776: Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity |
|
|
| Recruiting | N/A | 14500 | Europe | First-trimester preeclampsia screening (FMF triple test) | Assistance Publique - Hôpitaux de Paris, URC-CIC Paris Descartes Necker Cochin, INSERM, Epopé team | Preeclampsia (PE) | 10/25 | 10/25 | | |
| DESTRIEUX, Christophe |
| Recruiting | 3 | 486 | Europe | Intensified protocol, Stupp protocol | Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital | Glioblastoma | 05/25 | 11/27 | | |
| LABBE, Catherine |
NCT05714891: Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer |
|
|
| Active, not recruiting | 2 | 4 | Canada | JDQ443 | Canadian Cancer Trials Group, Novartis | NSCLC | 08/26 | 03/28 | | |
| RIVAL, Gilles |
BPCO, NCT05577767: Does Longitudinal Nursing Follow-up Improve Smoking Cessation in Patients Referred for COPD Screening |
|
|
| Recruiting | N/A | 233 | Europe | | Centre Hospitalier de Valence | COPD, Nurse's Role | 09/25 | 09/26 | | |
| HAGE, Wissam EL |
DISCO, NCT03758105: Transcranial Direct Current Stimulation (tDCS) Cost-utility-analysis in Medical Care on Depressive Episode With One Drug Therapy Failure. |
|
|
| Active, not recruiting | N/A | 214 | Europe | tDCS associated with usual care, Usual care | Nantes University Hospital | Depression | 11/23 | 11/23 | | |
| Recruiting | N/A | 150 | Europe | inflammatory, neuropsychological and neuroimaging assessment | Rennes University Hospital | Depression | 01/24 | 01/24 | | |
MINDDE, NCT05654948: Characterisation of Fundamental Decision Making in People Suffering From a Characterised Depressive Episode |
|
|
| Completed | N/A | 80 | Europe | computerised cognitive performance test : MindPulse, MindPulse | University Hospital, Tours | Depressive Episode | 04/24 | 04/24 | | |
| MULLEMAN, Denis |
| Recruiting | 3 | 220 | Europe, RoW | Abatacept (W12-W48), TNF Inhibitor (W12-W48), TNF Inhibitor (W0-W12) | University Hospital, Montpellier | Rheumatoid Arthritis | 11/24 | 11/25 | | |
| Recruiting | 3 | 178 | Europe, RoW | baricitinib treatment, adalimumab, Placebo | University Hospital, Bordeaux, Eli Lilly and Company, Biogen, Ministry for Health and Solidarity, France | Rheumatoid Arthritis | 12/25 | 12/25 | | |
RESPOND-IL17, NCT05812157: Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - |
|
|
| Recruiting | N/A | 36 | Europe | Daily dietary supplementation with Fibruline, Anti-IL-17 therapy | Centre Hospitalier Universitaire de Nīmes | Axial Spondyloarthritis | 12/26 | 12/26 | | |
| CAMUS, Vincent |
| Active, not recruiting | 3 | 240 | Europe, Canada, US, RoW | Brentuximab vedotin, Rituximab, Lenalidomide, Placebo | Seagen Inc. | Diffuse Large B-cell Lymphoma | 05/25 | 04/27 | | |
|
NCT03870776: RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode |
|
|
| Active, not recruiting | 2 | 110 | Europe | MAP4343, Placebo | Mapreg, Eurofins Optimed | Depression | 12/24 | 03/25 | | |
| Active, not recruiting | 2 | 82 | Europe, US, RoW | brentuximab vedotin, ADCETRIS, cyclophosphamide, doxorubicin, prednisone | Seagen Inc. | Peripheral T-cell Lymphoma | 05/24 | 12/25 | | |
| Recruiting | N/A | 100 | Europe | Physical exercises, Optional physical exercises | Centre Hospitalier Universitaire, Amiens, University Hospital, Rouen, University Hospital, Caen | Physical Activity, Multiple Myeloma, Quality of Life | 05/23 | 12/23 | | |
| Recruiting | N/A | 60 | Europe | Cerebral neuroinflammation evaluation | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Depressive Disorder | 01/24 | 01/24 | | |
CELERITY, NCT06744075: Study of the Clearance of Minimal Residual Disease Measured At the End of First-line Treatment in Patients with Lymphoma |
|
|
| Not yet recruiting | N/A | 108 | Europe | Blood assessment | Centre Henri Becquerel | B-cell Lymphoma, Hodgkin Lymphoma | 12/25 | 12/27 | | |
PEPAMARKER, NCT05384392: Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode |
|
|
| Not yet recruiting | N/A | 217 | Europe | Recorded interview, Clinical scales, Blood sample, MRI scans of the brain | University Hospital, Brest | First-episode Psychosis | 01/26 | 01/28 | | |
RT-CAR, NCT05675982: Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells |
|
|
| Not yet recruiting | N/A | 40 | Europe | CAR-T cells monitoring | Centre Henri Becquerel | Diffuse Large B Cell Lymphoma | 01/25 | 01/26 | | |
| Recruiting | N/A | 608 | Europe | RIPC, Simulated RIPC (Sham) | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, European Commission | Anthracycline-induced Cardiac Toxicity, Lymphoma | 08/25 | 05/26 | | |
| Not yet recruiting | N/A | 45 | Europe | circulating tumoral DNA detection | Centre Henri Becquerel | Peripheral T Cell Lymphoma | 11/25 | 11/26 | | |
| Recruiting | N/A | 87 | Europe | Circulating tumor DNA monitoring | Centre Henri Becquerel | Primary Mediastinal Large B-cell Lymphoma | 03/28 | 03/28 | | |
| Recruiting | N/A | 204 | Europe | Chemotherapy + follow up, Chemotherapy + ASCT + follow up | Hospices Civils de Lyon | Peripheral T Cell Lymphoma | 04/28 | 04/28 | | |
| GISSOT, Valérie |
REMBAU, NCT02423499: Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder |
|
|
| Recruiting | N/A | 90 | Europe | | University Hospital, Tours | Autism Spectrum Disorder, Bipolar Disorder | 05/21 | 05/21 | | |
| Recruiting | N/A | 30 | Europe | | University Hospital, Tours, Kahler Communication France | Communication, Personality | 09/21 | 12/21 | | |
| Completed | N/A | 815 | Europe, US, RoW | | BioMérieux, Vanderbilt University Medical Center, Centre d'Investigation Clinique - Limoges | Infection, Sepsis | 05/22 | 05/22 | | |
| Completed | N/A | 19 | Europe | 24h urine, urine sample | University Hospital, Tours | Lymphangioleiomyomatosis, Tuberous Sclerosis Complex | 10/22 | 10/22 | | |
| Recruiting | N/A | 60 | Europe | Cerebral neuroinflammation evaluation | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Depressive Disorder | 01/24 | 01/24 | | |
| Completed | N/A | 55 | Europe | Measure of visual acuity, Interferometry, Samples of basal tears, Central corneal sensitivity, Slit lamp examination and undilated fundus, Conjunctival impression, Evaluation of the corneal innervation | University Hospital, Tours | Amyotrophic Lateral Sclerosis | 09/23 | 09/23 | | |
COVIFERON, NCT06762002: Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort |
|
|
| Not yet recruiting | N/A | 500 | Europe | blood sample | Institut National de la Santé Et de la Recherche Médicale, France | Immunology, Allergy, Genetic Diseases, Infectious Diseases | 01/29 | 01/29 | | |
BARRIG, NCT06670937: Role of BARriers in IgG-Pathogen Interactions At the Mucosal Surface in Human Airways |
|
|
| Not yet recruiting | N/A | 30 | Europe | Induced sputum, Blood sample | University Hospital, Tours | Bronchiectasis Adult | 01/26 | 01/26 | | |
| COTTIER, Jean-Philippe |
| Recruiting | N/A | 60 | Europe | Cerebral neuroinflammation evaluation | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Depressive Disorder | 01/24 | 01/24 | | |
CAMOMILLE, NCT04113395: Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium |
|
|
| Recruiting | N/A | 500 | Europe | sequences T1 FE, T1 TFE sequences | Fondation Ophtalmologique Adolphe de Rothschild | Meningioma | 12/25 | 12/25 | | |
| Recruiting | N/A | 78 | Europe | MRI, Functionnal MRI, EEG, Electro Encephalography | University Hospital, Tours, INSERM UMR-1253, Tours, France | Autism Spectrum Disorder | 07/26 | 01/27 | | |
| RIBEIRO, Maria Joao SANTIAGO |
| Recruiting | 3 | 88 | Europe | PET/CT with 18F-DOPA | Central Hospital, Nancy, France | Glioma | 12/25 | 10/26 | | |
| Recruiting | 2 | 51 | US | High dose testosterone, Bipolar androgen therapy | VA Office of Research and Development | Metastatic Prostate Cancer | 08/26 | 08/27 | | |
| Completed | N/A | 119 | Europe | | Association for Innovation and Biomedical Research on Light and Image | Diabetic Retinopathy | 03/24 | 03/24 | | |
| Active, not recruiting | N/A | 3500 | US, RoW | Therapeutic | National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI) | Myelodysplastic Syndromes (MDS) | 03/25 | 06/25 | | |
| Active, not recruiting | N/A | 100 | Europe | | Association for Innovation and Biomedical Research on Light and Image | Eye Disease | 12/26 | 12/26 | | |
| BLOUIN, Pascale |
CAALL-F01, NCT02716233: A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents |
|
|
| Recruiting | 3 | 1578 | Europe | pegaspargase 1250 IU/m2 x 2, ONCASPAR 1250 IU/m2 x 2, pegaspargase 2500 IU/m2 x 1, ONCASPAR 2500 IU/m2 x 1 | Assistance Publique - Hôpitaux de Paris, Shire | Acute Lymphoblastic Leukemia | 04/26 | 04/26 | | |
| Recruiting | 2/3 | 536 | Europe, RoW | 16 weeks of VEC + CDDP, Vincristine, Etoposide, Cyclophosphamide, Cisplatin, VEC + HD-MTX, Methotrexate, Chemotherapy + Valproate, Carboplatin, Valproate, Conformal radiotherapy, VEC, Chemotherapy, conformal radiotherapy +/- boost | Centre Leon Berard | Childhood Ependymoma | 06/28 | 08/31 | | |
| Recruiting | 2/3 | 225 | Europe | Melphalan or Melphalan + Topotecan, Alkeran, Topotecan Accord; Topotecan Hospira chemotherapy, etoposide, carboplatin and vincristine or local ophthalmological treatment without IV chemotherapy, etoposide, carboplatin and vincristine chemotherapy, Carboplatin administered on Day 1, platinum-based chemotherapy, Thermotherapy (local treatment), Thermotherapy after carboplatin administered on Day 1, Cryotherapy (local treatment), Iodine-125 plaques (local treatment), Intravitreal Melphalan chemotherapy injections (local treatment) | Institut Curie, Fondation Rothschild Paris | Retinoblastoma | 01/35 | 01/36 | | |
| Active, not recruiting | 2 | 133 | Europe | VP16, carboplatin, etoposide, vepesid, chemotherapy, Melphalan, Alkeran, chemotherapy, VP16, carboplatin, vincristin, etoposide, vepesid, leurocristine, Oncovin, chemotherapy, Carboplatin + laser day 1 (chemothermotherapy), Carbo-laser, platinum-based chemotherapy, Laser (local treatment), Laser diode, cryoapplication (local treatment), I125 radioactive plaques (local treatment), intravitreal Melphalan (local treatment) | Institut Curie, Fondation Rothschild Paris | Retinoblastoma, Children, Retinal Neoplasm | 01/23 | 09/35 | | |
| Recruiting | 2 | 185 | Europe | Observation, Low risk group, Etoposide, Intermediate risk sub group 1, Vincristine, Intermediate risk sub group 2, Orbital irradiation, High risk group, Carboplatin, Cyclophosphamide, Thiotepa, Cytapheresis, Peripheral bood stem cell transplantation | Institut Curie | Retinoblastoma | 03/30 | 09/30 | | |
| Recruiting | N/A | 40 | Europe | Biological sampling in patients, Biological sampling in control patients | University Hospital, Tours | Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children | 10/26 | 10/28 | | |
MICCHADO, NCT03496402: Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults |
|
|
| Active, not recruiting | N/A | 600 | Europe | Sampling on blood, bone marrow and cerebrospinal fluid | Institut Curie | Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors, Osteosarcoma, Leukemia, Central Nervous System Tumor | 04/27 | 08/27 | | |
| Machet, Laurent |
RITUX-MMP, NCT03295383: Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid |
|
|
| Recruiting | 3 | 130 | Europe | Rituximab 1g IV, Cyclophosphamide 50Mg Oral Tablet, Placebo of Rituximab, Placebo Oral Tablet | University Hospital, Rouen | Severe Forms of Mucous Membrane Pemphigoid | 11/22 | 11/23 | | |
CANNABITCH, NCT06435299: Efficacy and Tolerance of Cannabidiol in Patients with Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study |
|
|
| Not yet recruiting | 3 | 218 | Europe | Cannabis oil, Placebo | University Hospital, Brest | Pruritus | 07/27 | 07/27 | | |
| Active, not recruiting | 2 | 170 | Europe, US | IPH4102, lacutamab | Innate Pharma | Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome | 10/23 | 01/26 | | |
|
|
|
|
|
|
| Active, not recruiting | 2 | 271 | Europe | Nivolumab + Ipilimumab, Encorafenib + Binimetinib | European Organisation for Research and Treatment of Cancer - EORTC | Unresectable Stage III Melanoma, Stage IV Melanoma | 10/23 | 01/27 | | |
| Recruiting | N/A | 225 | Europe | Sampling | University Hospital, Tours | Vasculitis | 12/37 | 12/37 | | |
| Recruiting | N/A | 9000 | Europe | | University Hospital, Lille | Adnexal Tumor of Skin, Merkel Cell Carcinoma, Advanced Basal Cell Carcinoma Requiring Systemic Treatment | 12/25 | 12/25 | | |
| MAILLOT, François |
| Recruiting | N/A | 225 | Europe | Sampling | University Hospital, Tours | Vasculitis | 12/37 | 12/37 | | |
MATAC, NCT06444477: Molecular Analysis of Thrombocytopenia and Cancer (): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer |
|
|
| Not yet recruiting | N/A | 70 | Europe | ITP and cancer | University Hospital, Bordeaux | Immune Thrombocytopenia, Immune Thrombocytopenic Purpura, Neoplasms, Cancer | 12/24 | 12/24 | | |
| Recruiting | N/A | 350 | Europe | Blood samples, Tracheal Aspirates, Surplus of Broncho-alveolar lavage fluid | University Hospital, Tours | Community-acquired Pneumonia, Acute Respiratory Distress Syndrome, Innate Immunity | 09/24 | 03/25 | | |
| Maruani, Annabel |
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata |
|
|
| Recruiting | 3 | 595 | Europe, Canada, Japan, US, RoW | Baricitinib, LY3009104, Placebo | Eli Lilly and Company | Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical | 09/24 | 08/29 | | |
| Recruiting | 2 | 12 | Europe | Sirolimus Oral Liquid Product 1mg/mL, Experimental treatment | University Hospital, Tours | Lingual Microcystic Lymphatic Malformations | 02/25 | 07/25 | | |
SESAM, NCT05577754: Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients with Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP) |
|
|
| Recruiting | 2 | 20 | Europe | Alpelisib (BYL719), Matching placebo, Optional lumbar puncture + blood sample | Centre Hospitalier Universitaire Dijon, Novartis Pharmaceuticals | Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP) | 03/27 | 03/27 | | |
NCT04451902: COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic |
|
|
| Recruiting | N/A | 80 | Europe, RoW | | Imagine Institute | Rare Diseases | 04/22 | 12/22 | | |
| Recruiting | N/A | 250 | Europe | Questionnaire | University Hospital, Tours, INSERM UMR 1246 SPHERE | Acceptance of Visible Chronic Dermatological Disease, Disease Acceptance, Psychological Well-Being, Social Segregation | 12/25 | 12/25 | | |
| Recruiting | N/A | 900 | Europe | | Institut National de la Santé Et de la Recherche Médicale, France | Inherited Epidermolysis Bullosa, Ichthyosis, Ectodermal Dysplasia, Incontinentia Pigmenti, Neurofibromatosis Type 1, Albinism, Pemphigus, Mucous Membrane Pemphigoid, Palmoplantar Keratoderma | 03/27 | 03/27 | | |
COVER, NCT04352036: Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the Cohort (Verneuil Cohort) |
|
|
| Recruiting | N/A | 465 | Europe | no interventional study | Nantes University Hospital | Acute Hidrosadenitis | 02/30 | 02/30 | | |
| Beaufils, Emilie |
| Not yet recruiting | N/A | 3360 | Europe | | Hospices Civils de Lyon | Puberty, Precocious | 03/28 | 03/28 | | |
| Santiago-Ribeiro, Maria-Joao |
| Recruiting | 3 | 152 | Europe | SPECT, PET | Zionexa | Parkinson Disease, Essential Tremor | 09/24 | 12/24 | | |
| Recruiting | N/A | 60 | Europe | Cerebral neuroinflammation evaluation | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Depressive Disorder | 01/24 | 01/24 | | |
| GISSOT, Valerie |
PINK-AD, NCT04570761: Effects of Auditory Brain Stimulation by "Pink Noise" on Memory Capacities in Alzheimer's Disease: Proof of Concept Study |
|
|
| Recruiting | N/A | 30 | Europe | Dreem headband | University Hospital, Tours | Alzheimer's Disease (AD) | 03/24 | 03/24 | | |
| ZEMMOURA, Ilyess |
| Recruiting | 3 | 486 | Europe | Intensified protocol, Stupp protocol | Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital | Glioblastoma | 05/25 | 11/27 | | |
POLO, NCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery |
|
|
| Recruiting | 3 | 280 | Europe | PCV chemotherapy, Radiotherapy and PCV chemotherapy | Hospices Civils de Lyon | Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion | 12/30 | 12/30 | | |
| Stephan, Jean-Louis |
| Recruiting | 2/3 | 225 | Europe | Melphalan or Melphalan + Topotecan, Alkeran, Topotecan Accord; Topotecan Hospira chemotherapy, etoposide, carboplatin and vincristine or local ophthalmological treatment without IV chemotherapy, etoposide, carboplatin and vincristine chemotherapy, Carboplatin administered on Day 1, platinum-based chemotherapy, Thermotherapy (local treatment), Thermotherapy after carboplatin administered on Day 1, Cryotherapy (local treatment), Iodine-125 plaques (local treatment), Intravitreal Melphalan chemotherapy injections (local treatment) | Institut Curie, Fondation Rothschild Paris | Retinoblastoma | 01/35 | 01/36 | | |
| Active, not recruiting | 2 | 133 | Europe | VP16, carboplatin, etoposide, vepesid, chemotherapy, Melphalan, Alkeran, chemotherapy, VP16, carboplatin, vincristin, etoposide, vepesid, leurocristine, Oncovin, chemotherapy, Carboplatin + laser day 1 (chemothermotherapy), Carbo-laser, platinum-based chemotherapy, Laser (local treatment), Laser diode, cryoapplication (local treatment), I125 radioactive plaques (local treatment), intravitreal Melphalan (local treatment) | Institut Curie, Fondation Rothschild Paris | Retinoblastoma, Children, Retinal Neoplasm | 01/23 | 09/35 | | |
| Recruiting | 2 | 185 | Europe | Observation, Low risk group, Etoposide, Intermediate risk sub group 1, Vincristine, Intermediate risk sub group 2, Orbital irradiation, High risk group, Carboplatin, Cyclophosphamide, Thiotepa, Cytapheresis, Peripheral bood stem cell transplantation | Institut Curie | Retinoblastoma | 03/30 | 09/30 | | |
| Recruiting | N/A | 16 | Europe, Japan, US, RoW | genetic restrospective study | Institut National de la Santé Et de la Recherche Médicale, France | Immune Deficiency, Autoimmune Diseases, Infections, Diagnosis | 08/26 | 01/27 | | |
| Recruiting | N/A | 300 | Europe, RoW | Collection of blood sample or saliva, Collection of a tumor sample taken before the participation of the patient in study, Collection of blood sample if tumor sample is not available | University Hospital, Angers | Predisposition, Genetic, Cancer Childhood, Development Delay | 02/25 | 08/25 | | |
| Desmidt, Thomas |
NCT03454646: Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) |
|
|
| Not yet recruiting | 4 | 1205 | Europe | cholinesterase inhibitors (CI) (donepezil, galantamine or rivastigmine) | University Hospital, Bordeaux | Alzheimer Disease, Cholinesterase Inhibitors | 04/27 | 09/27 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
| Recruiting | N/A | 60 | Europe | EMONO, Medical Air | University Hospital, Tours | Late-Life Depression, Resistant Depression, Treatment | 12/24 | 12/24 | | |
| Recruiting | N/A | 60 | Europe | Cerebral neuroinflammation evaluation | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Depressive Disorder | 01/24 | 01/24 | | |
| Recruiting | N/A | 300 | Europe | Ultrasound examination | University Hospital, Tours | Neurocognitive Disorders | 03/26 | 03/31 | | |
| TAUVERON, Valerie |
ACTIODERM, NCT04252690: Physiological Study to Assess Mechanism of Action of MOBIDERM® in Lower-limb Lymphedema Patients |
|
|
| Completed | N/A | 9 | Europe | MOBIDERM® autofit : auto-adjustable compression stocking | Thuasne, University Hospital, Tours, Delta Consultants | Lymphedema of Leg, Lymphedema Congenital, Lymphedema Primary, Lymphedema, Secondary | 06/22 | 06/22 | | |
LYMphoNIGHT, NCT04203069: Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase |
|
|
| Completed | N/A | 63 | Europe, RoW | Control group : Day-time compression sleeve, Intervention group : Day-time compression sleeve and Night-time MOBIDERM® Autofit | Thuasne, International Clinical Trials Association | Lymphedema of Upper Arm | 12/23 | 09/24 | | |
| D'ALTEROCHE, Louis |
| Completed | N/A | 104 | Europe | Transjugular Portosytemic Shunt (TIPS), glue obliteration | Centre Hospitalier Universitaire de Besancon | Bleeding Gastric Varices, Cirrhosis | 03/23 | 02/24 | | |
| Recruiting | N/A | 800 | Europe | Blood draw for the laboratory assessment | ANRS, Emerging Infectious Diseases | Hepatitis D, Chronic, Hepatitis B, Chronic | 12/27 | 06/28 | | |
| MORINIERE, Sylvain |
| Recruiting | 3 | 1100 | Europe, US, RoW | Cisplatin, Postoperative radiotherapy | Lisette Nixon, UNICANCER, AdventHealth, University of Leipzig, Princess Alexandra Hospital, Brisbane, Australia, Stanford University | Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer | 10/26 | 04/27 | | |
| Recruiting | N/A | 150 | Europe | transoral resection, IMRT | Gustave Roussy, Cancer Campus, Grand Paris | Squamous Cell Carcinoma | 06/29 | 06/29 | | |
| Recruiting | N/A | 520 | Europe | Swallowing evaluation | University Hospital, Toulouse, National Research Agency, France, Institut de Recherche en Informatique de Toulouse (IRIT), Laboratoire parole et langage, Swallis Medical | Swallowing Disorders | 12/24 | 06/25 | | |
| SALAME, Ephrem |
HALT, NCT06535945: Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation |
|
|
| Not yet recruiting | 4 | 400 | Europe | Albumin administration | Rennes University Hospital, Ministry of Health, France | Liver Transplantation, Acute Kidney Injury | 03/28 | 04/28 | | |
Ta-Len-Tra, NCT05901194: Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma |
|
|
| Not yet recruiting | 1/2 | 25 | Europe | Lenvatinib | Assistance Publique - Hôpitaux de Paris, Laboratoire EISAI | Hepatocellular Carcinoma Non-resectable | 12/26 | 07/27 | | |
BIOSUPORT, NCT03997253: Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management |
|
|
| Recruiting | N/A | 430 | Europe | blood and urine samples | University Hospital, Limoges, University Hospital Federation FHU SUPORT | Organ Transplantation | 02/25 | 11/25 | | |
| Clinique, Centre d'Investigation |
NCT06035367: SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes |
|
|
| Recruiting | N/A | 10 | Europe | Non-invasive continuous monitoring device to record photoacoustic signal | Eclypia | Diabetes | 10/23 | 10/23 | | |
| Clementy, Nicolas |
| Recruiting | N/A | 50 | Europe | Cardioneuroablation | University Hospital, Bordeaux | Syncope, Vasovagal, Bradycardia, Heart Arrest | 01/26 | 01/26 | | |
| Recruiting | N/A | 1000 | Europe, RoW | DiamondTemp™ Ablation System | Medtronic Cardiac Rhythm and Heart Failure | Arrhythmia | 03/31 | 03/31 | | |
| Suspended | N/A | 50 | Europe | Non invasive epicardial mapping, Cardio Insight system, ECG imaging | University Hospital, Tours | Cardiac Resynchronization Therapy | 12/25 | 12/25 | | |
| Recruiting | N/A | 50 | Europe | Single-chamber pacemaker implantation with left bundle branch area pacing, Atrioventricular junction ablation | Nicolas Clementy, MD, PhD, Dr Arnaud BISSON | Pacing-Induced Cardiomyopathy | 05/22 | 10/22 | | |
| Pierre, Bertrand |
NCT04619888: HeartLogic France Study: Heart Failure Patients Managed With the HeartLogic Algorithm |
|
|
| Recruiting | N/A | 310 | Europe | HeartLogic | Poitiers University Hospital | Heart Failure | 07/23 | 07/23 | | |
| Active, not recruiting | N/A | 92 | Europe | Implantation of the Axone 4LV Lead | MicroPort CRM | Heart Failure, Cardiac Resynchronization Therapy | 06/24 | 12/27 | | |
